Tahoe Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$35M
- Investors
-
12
Tahoe Therapeutics General Information
Description
Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. The company's platform engages in generating scalable, single-cell precision to capture the context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays, enabling doctors to improve the failure rate of drugs in clinical trials.
Contact Information
Website
www.tahoelabs.aiCorporate Office
- 490 Forbes Boulevard
- Suite 3B
- South San Francisco, CA 94107
- United States
Corporate Office
- 490 Forbes Boulevard
- Suite 3B
- South San Francisco, CA 94107
- United States
Tahoe Therapeutics Timeline
Tahoe Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 11-Aug-2025 | $35M | Completed | Generating Revenue | ||
| 3. Seed Round | Completed | Generating Revenue | ||||
| 2. Accelerator/Incubator | 01-May-2024 | $12M | Completed | Generating Revenue | ||
| 1. Seed Round | 08-Dec-2022 | $12M | $12M | Completed | Generating Revenue |
Tahoe Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-1 | ||||||||
| Seed | 5,961,069 | $0.000100 | $2.06 | $2.06 | 1x | $2.06 | 17.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Tahoe Therapeutics Comparisons
Industry
Financing
Details
Tahoe Therapeutics Competitors (2)
One of Tahoe Therapeutics’s 2 competitors is Numerion Labs, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Numerion Labs | Venture Capital-Backed | San Francisco, CA | ||||
| insitro | Venture Capital-Backed | South San Francisco, CA |
Tahoe Therapeutics Patents
Tahoe Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025090966-A1 | Mek inhibitors, alone or in combination with cdk4/5 inhibitors, for use in treating cancer | Inactive | 26-Oct-2023 |
Tahoe Therapeutics Signals
Tahoe Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amplify Partners | Venture Capital | Minority | ||
| Civilization Ventures | Venture Capital | Minority | ||
| Conviction Partners | Venture Capital | Minority | ||
| Databricks Ventures | Corporate Venture Capital | Minority | ||
| Mubadala Investment Company | Sovereign Wealth Fund | Minority |
Tahoe Therapeutics Investments (1)
Tahoe Therapeutics’s most recent deal was a Joint Venture with Developing Antibody Drug (Alloy Therapeutics / Tahoe). The deal was made on 13-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Developing Antibody Drug (Alloy Therapeutics / Tahoe) | 13-Jan-2026 | Joint Venture | Drug Discovery |
Tahoe Therapeutics FAQs
-
When was Tahoe Therapeutics founded?
Tahoe Therapeutics was founded in 2022.
-
Where is Tahoe Therapeutics headquartered?
Tahoe Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Tahoe Therapeutics?
Tahoe Therapeutics has 36 total employees.
-
What industry is Tahoe Therapeutics in?
Tahoe Therapeutics’s primary industry is Drug Discovery.
-
Is Tahoe Therapeutics a private or public company?
Tahoe Therapeutics is a Private company.
-
What is the current valuation of Tahoe Therapeutics?
The current valuation of Tahoe Therapeutics is .
-
What is Tahoe Therapeutics’s current revenue?
The current revenue for Tahoe Therapeutics is .
-
How much funding has Tahoe Therapeutics raised over time?
Tahoe Therapeutics has raised $50M.
-
Who are Tahoe Therapeutics’s investors?
Amplify Partners, Civilization Ventures, Conviction Partners, Databricks Ventures, and Mubadala Investment Company are 5 of 12 investors who have invested in Tahoe Therapeutics.
-
Who are Tahoe Therapeutics’s competitors?
Numerion Labs and insitro are competitors of Tahoe Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process